MediZues is a service that allows Medicare agents to see when their clients switch their Medicare Advantage Prescription Drug (MAPD), Medicare Advantage (MA-only), or Prescription Drug Plan (PDP). The platform notifies agents within 12 hours of when CMS approves a future enrollment, providing details like the future plan contract and name.

MediZues is fully compliant with HIPAA and is SOC 2 Type II certified. All data is encrypted in transit and at rest. The system’s full encryption ensures that MediZues cannot view user data, prioritizing client confidentiality and data security. Additionally, you can view our Trust report which offers real-time monitoring of our systems.

1. Study the future plan’s Summary of Benefits (most of them are listed here).
2. Compare the future plan against their current plan with you.
3. Contact your upline on how to best handle the rest.

According to CMS, an agent may “contact the disenrolling beneficiary to conduct a disenrollment survey for quality improvement purposes.” As referenced in 42 CFR 422.2264(a)(2)(iv)(B)

It is non-compliant to contact a beneficiary after they have disenrolled and you are no longer their Agent On Record (AOR).